[ET Net News Agency, 3 June 2026] HANSOH PHARMA (03692) fell 3% to HK$30.1.
It hits an intra-day low of HK$30.08, hitting an 1-month low, and an intra-day high of HK$31.04. The total shares traded was 2.45 million, with a value of HK$74.56m. The active buy/sell ratio is 56:44, with net buying turnover of HK$8.49m. UBS accounts for greatest net responsive buying turnover of HK$2.53m, with volume weighted average price of HK$30.425. CLSA LTD accounts for greatest net responsive selling turnover of HK$12.12m, with volume weighted average price of HK$30.339. The stock has fallen a combined 4.3% over the past 3 consecutive trading days.
The Hang Seng Index now fell 272 points, or 1% to 25,765.
Basic Information| Nominal | 30.100 | % Chg | -2.97% |
| High | 31.040 | Low | 30.080 |
| Shares Tr | 2.45m | Turnover | 74.56m |
| 10-D SMA | 32.430 | %H.V | 31.950 |
| 20-D SMA | 34.185 | VWAP | 30.385 |
| 50-D SMA | 35.688 | RSI14 | 22.644 |
Status: Hitting an 1-month low, active buy/sell ratio is 56:44, with net buying turnover of HK$8.49m, falling a combined 4.3% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 30.10 | -2.97 |
| SIHUAN PHARM (00460) | 0.94 | -2.08 |
| GRAND PHARMA (00512) | 5.20 | -1.52 |
| SBP GROUP (01177) | 4.75 | -2.66 |
| HENGRUI PHARMA (01276) | 57.10 | -2.97 |
| LIVZON PHARMA (01513) | 26.46 | -0.97 |
| LUYE PHARMA (02186) | 2.14 | -2.73 |
| FOSUN PHARMA (02196) | 16.68 | -2.46 |
| SH PHARMA (02607) | 11.56 | -1.03 |
| CHINARES PHARMA (03320) | 4.74 | -1.25 |
(ed)
